BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 20559316)

  • 1. An update on sphingosine-1-phosphate and other sphingolipid mediators.
    Fyrst H; Saba JD
    Nat Chem Biol; 2010 Jul; 6(7):489-97. PubMed ID: 20559316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate.
    Laviad EL; Albee L; Pankova-Kholmyansky I; Epstein S; Park H; Merrill AH; Futerman AH
    J Biol Chem; 2008 Feb; 283(9):5677-84. PubMed ID: 18165233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oroscomucoid like protein 3 (ORMDL3) transgenic mice have reduced levels of sphingolipids including sphingosine-1-phosphate and ceramide.
    Miller M; Rosenthal P; Beppu A; Gordillo R; Broide DH
    J Allergy Clin Immunol; 2017 Apr; 139(4):1373-1376.e4. PubMed ID: 27826095
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioactive sphingolipids: Advancements and contributions from the laboratory of Dr. Lina M. Obeid.
    Velazquez FN; Hernandez-Corbacho M; Trayssac M; Stith JL; Bonica J; Jean B; Pulkoski-Gross MJ; Carroll BL; Salama MF; Hannun YA; Snider AJ
    Cell Signal; 2021 Mar; 79():109875. PubMed ID: 33290840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine-1-Phosphate Metabolism and Signaling in Kidney Diseases.
    Drexler Y; Molina J; Mitrofanova A; Fornoni A; Merscher S
    J Am Soc Nephrol; 2021 Jan; 32(1):9-31. PubMed ID: 33376112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer treatment strategies targeting sphingolipid metabolism.
    Oskouian B; Saba JD
    Adv Exp Med Biol; 2010; 688():185-205. PubMed ID: 20919655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
    Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
    Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.
    Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B
    Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear lipid mediators: Role of nuclear sphingolipids and sphingosine-1-phosphate signaling in epigenetic regulation of inflammation and gene expression.
    Fu P; Ebenezer DL; Ha AW; Suryadevara V; Harijith A; Natarajan V
    J Cell Biochem; 2018 Aug; 119(8):6337-6353. PubMed ID: 29377310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingolipids in mammalian cell signalling.
    Ohanian J; Ohanian V
    Cell Mol Life Sci; 2001 Dec; 58(14):2053-68. PubMed ID: 11814056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of sphingosine kinase-1 in cancer: implications for therapeutic targeting.
    Cuvillier O; Ader I; Bouquerel P; Brizuela L; Malavaud B; Mazerolles C; Rischmann P
    Curr Mol Pharmacol; 2010 Jun; 3(2):53-65. PubMed ID: 20302564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Principles of bioactive lipid signalling: lessons from sphingolipids.
    Hannun YA; Obeid LM
    Nat Rev Mol Cell Biol; 2008 Feb; 9(2):139-50. PubMed ID: 18216770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine kinase localization in the control of sphingolipid metabolism.
    Siow DL; Anderson CD; Berdyshev EV; Skobeleva A; Natarajan V; Pitson SM; Wattenberg BW
    Adv Enzyme Regul; 2011; 51(1):229-44. PubMed ID: 21075134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S1P metabolism in cancer and other pathological conditions.
    Leong WI; Saba JD
    Biochimie; 2010 Jun; 92(6):716-23. PubMed ID: 20167244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine 1-phosphate is a key metabolite linking sphingolipids to glycerophospholipids.
    Kihara A
    Biochim Biophys Acta; 2014 May; 1841(5):766-72. PubMed ID: 23994042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of sphingolipids in selected cardiovascular diseases].
    Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Chabowska A; Łukaszuk B; Żendzian-Piotrowska M
    Postepy Hig Med Dosw (Online); 2013 Sep; 67():1018-26. PubMed ID: 24088546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity.
    Tabuchi K; Hara A
    Curr Mol Pharmacol; 2018; 11(4):279-284. PubMed ID: 29766830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine phosphate lyase insufficiency syndrome (SPLIS): A novel inborn error of sphingolipid metabolism.
    Choi YJ; Saba JD
    Adv Biol Regul; 2019 Jan; 71():128-140. PubMed ID: 30274713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High levels of sphingolipids in human breast cancer.
    Nagahashi M; Tsuchida J; Moro K; Hasegawa M; Tatsuda K; Woelfel IA; Takabe K; Wakai T
    J Surg Res; 2016 Aug; 204(2):435-444. PubMed ID: 27565080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of sphingolipids in endothelial barrier function.
    Jernigan PL; Makley AT; Hoehn RS; Edwards MJ; Pritts TA
    Biol Chem; 2015 Jun; 396(6-7):681-91. PubMed ID: 25867999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.